The Shareholders’ Meeting of Siegfried Holding AG today approved all proposals by the Board of Directors. It endorsed a higher distribution to the Shareholders of CHF 2.40 per share (2017: CHF 2.00). All members of the Board were reconfirmed. The proposals regarding remuneration of the members of the Board of Directors and of Management have been approved.
Siegfried’s 115th Annual Shareholders’ Meeting took place at the Zofingen City Hall and was attended by over 200 shareholders and proxies representing more than 50% of the shares. The Shareholders took the following decisions:
Peter Gehler, Chief Communications Officer
Tel. +41 62 746 11 48
Mobile +41 79 416 41 16
Siegfried Holding AG
Untere Bruehlstrasse 4
Tel. +41 62 746 11 11
The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, the USA, Malta, China, Germany and France. At the end of 2017, Siegfried reported annual sales of CHF 751 million and employs at the time being approximately 2300 employees at nine locations on three continents. Siegfried Holding AG is listed on the Swiss Exchange (SIX: SFZN)
Siegfried is active in both the primary and secondary production of drugs. The company manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediates and controlled substances, and provides development and production services for finished dosage forms including sterile filling.